In consultation: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Consultation end date

Consultation end date

Type

Type

Guidance programme

Showing 1 to 10 of 15

TitleConsultationTypeConsultation end date
Osteoporosis: risk assessment, treatment, and fragility fracture prevention (update)Draft guidance consultationNICE guideline
Perioperative care in adultsQuality standard consultationQuality standard
Zanidatamab for treating HER2-positive advanced biliary tract cancer after 1 or more systemic treatments [ID6388]Draft guidanceTechnology appraisal guidance
Suspected Cancer: recognition and referral (update)Draft guidance consultationNICE guideline
Daratumumab with bortezomib, lenalidomide and dexamethasone for untreated multiple myeloma when a stem cell transplant is unsuitable [ID3843]Draft guidanceTechnology appraisal guidance
Domestic AbuseDraft scope consultationNICE guideline
Lifileucel for previously treated unresectable or metastatic melanoma ID3863Draft guidanceTechnology appraisal guidance
Filgotinib for treating axial spondyloarthritis ID6594Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Digital technologies for applying algorithms to spirometry to support asthma and COPD diagnosis in primary care and community diagnostic centres: early-use assessmentDraft guidanceHealth technology evaluation
Brexucabtagene autoleucel for treating relapsed or refractory mantle cell lymphoma after 2 or more systemic treatments (review of TA677) [ID6325]Final draft guidanceTechnology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All